BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 356029)

  • 1. Pretransplant assays of alloimmunity in predicting renal graft outcome.
    Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
    Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
    Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
    Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of immunological anti-donor reactivity in renal allotransplanted patients--a prospective study.
    Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen S; Jørgensen F; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1977; (42):46-50. PubMed ID: 356221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of humoral presenitization in human renal transplant rejection.
    Gailiunas P; Suthanthiran M; Busch GJ; Carpenter CB; Garovoy MR
    Kidney Int; 1980 May; 17(5):638-46. PubMed ID: 6995691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antidonor antibody: advantages of fibroblast target cells.
    Halloran PF; Aprile M; Haddad G; Robinette M
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients.
    Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J
    J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-donor antibody responses. Recipient presensitization and renal allograft survival.
    Keown P; Stiller CR; Sinclair NR; Fung M; McGirr D; Moseley P; Howson W; Ulan RA
    Transplant Proc; 1978 Jun; 10(2):459-62. PubMed ID: 354135
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic monitoring in the diagnosis of renal allograft rejection.
    Gailiunas P; Suthanthiran M; Person A; Carpenter CB; Garovoy MR
    Transplant Proc; 1977 Dec; 9(4):1823-5. PubMed ID: 341443
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic correlates of human renal allograft survival.
    Etheredge EE; Sicard GA; Anderson CB
    Transplant Proc; 1979 Mar; 11(1):354-9. PubMed ID: 377655
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular and humoral immunity after clinical renal transplantation.
    Arnesen E; Bondevik H; Thorsby E
    Proc Eur Dial Transplant Assoc; 1975; 11():343-50. PubMed ID: 1105555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-donor serum (ADS) and donor cells on renal allograft survival in DL-A tissue-typed littermate beagles.
    Jeekel J; Obertop H; Vriesendorp HM; McDicken I; Westbroek DL
    Transplant Proc; 1975 Sep; 7(3):435-8. PubMed ID: 1099744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
    Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
    Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.